Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / CL A
-
Number of holders
-
143
-
Total 13F shares, excl. options
-
26,709,939
-
Shares change
-
-125,352
-
Total reported value, excl. options
-
$704,321,572
-
Value change
-
-$124,191,199
-
Put/Call ratio
-
69%
-
Number of buys
-
73
-
Number of sells
-
-109
-
Price
-
$26.37
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q4 2021
227 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q4 2021.
REATA PHARMACEUTICALS INC - CL A (RETA) has 143 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,709,939 shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4,252,977 shares), CPMG Inc (2,896,901 shares), VANGUARD GROUP INC (2,557,673 shares), Invesco Ltd. (2,280,409 shares), BlackRock Inc. (2,114,050 shares), GOLDMAN SACHS GROUP INC (1,182,570 shares), PRICE T ROWE ASSOCIATES INC /MD/ (966,011 shares), FRANKLIN RESOURCES INC (852,263 shares), STATE STREET CORP (668,614 shares), and DEUTSCHE BANK AG\ (649,654 shares).
This table shows the top 143 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.